⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
KLAR SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Klarna (KLAR) Investors of Securities Class Action Deadline on February 20, 2026 Ready to Announce with Confidence?
newsfilecorp.com
KLAR
BYND
VTGN
VTGN SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Vistagen (VTGN) Investors of the Securities Class Action Lawsuit Deadline on March 16, 2026 Ready to Announce with Confidence?
newsfilecorp.com
VTGN
Pomerantz LLP Alerts Shareholders to Investor Suit Involving Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN Shareholders Have Opportunity to Lead Vistagen Therapeutics, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
VTGN
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
Pomerantz LLP Alerts Shareholders to Investor Suit Filed Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
accessnewswire.com
VTGN
Pomerantz LLP Alerts Shareholders to Investor Suit Against Vistagen Therapeutics, Inc. – VTGN
accessnewswire.com
VTGN
VTGN Investors Encouraged to Seek Lead Plaintiff Role in Vistagen Therapeutics Securities Class Actoin Case with Johnson Fistel
globenewswire.com
VTGN